Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long Term Depressed Mood”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT06605105
What this trial is testing

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

Who this might be right for
Major Depressive Disorder
Cybin IRL Limited 468
Not applicableStudy completedNCT05516368
What this trial is testing

TF-CBT for Long-term PTSD, Major Depressive Disorder and Anxiety Disorders in Victims of Terrorism

Who this might be right for
Posttraumatic Stress DisorderMajor Depressive DisorderAnxiety Disorders
Universidad Complutense de Madrid 120
Large-scale testing (Phase 3)Study completedNCT00224510
What this trial is testing

Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium

Who this might be right for
Bipolar DisorderBipolar Depression
GlaxoSmithKline 120
Large-scale testing (Phase 3)Study completedNCT01838876
What this trial is testing

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 442
Not applicableStudy completedNCT00001435
What this trial is testing

Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children

Who this might be right for
Acquired Immunodeficiency SyndromeDepressive DisorderHIV Infections
National Cancer Institute (NCI) 110
Not applicableStudy completedNCT01453699
What this trial is testing

Long-term Consequences of Bereavement in Children, Adolescents and Young Adults

Who this might be right for
Bereavement
Danish Cancer Society 1,225,660
Post-approval studies (Phase 4)Looking for participantsNCT05450432
What this trial is testing

Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 100
Not applicableLooking for participantsNCT03320304
What this trial is testing

Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.

Who this might be right for
Treatment Resistant Depression
LivaNova 500
Testing effectiveness (Phase 2)Ended earlyNCT04634669
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
Axsome Therapeutics, Inc. 181
Not applicableStudy completedNCT01439269
What this trial is testing

Family Nurture Intervention (FNI) in Neonatal Intensive Care Unit (NICU)

Who this might be right for
Premature Birth
Columbia University 394
Large-scale testing (Phase 3)Enrolling By InvitationNCT07217860
What this trial is testing

An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)

Who this might be right for
Bipolar DepressionBipolar I DisorderBipolar Disorder+1 more
Xenon Pharmaceuticals Inc. 400
Large-scale testing (Phase 3)Study completedNCT00855530
What this trial is testing

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorders
Sanofi 527
Large-scale testing (Phase 3)Study completedNCT00250653
What this trial is testing

A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression

Who this might be right for
Depressive Disorder
Sanofi 365
Large-scale testing (Phase 3)Ended earlyNCT03668600
What this trial is testing

Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 230
Post-approval studies (Phase 4)Active Not RecruitingNCT05698394
What this trial is testing

Effect of Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth

Who this might be right for
Prenatal DepressionKetaminePostpartum Depression
Peking University First Hospital 364
Not applicableUnknownNCT04021433
What this trial is testing

Ketamine for Treatment Resistant MDD

Who this might be right for
Depressive Disorder, Major
Hadassah Medical Organization 20
Not applicableLooking for participantsNCT04877977
What this trial is testing

Long-term Observation of Participants With Mood Disorders

Who this might be right for
DepressionSuicide Risk
National Institute of Mental Health (NIMH) 1,000
Post-approval studies (Phase 4)Study completedNCT00406848
What this trial is testing

A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 370
Large-scale testing (Phase 3)Study completedNCT02497287
What this trial is testing

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Who this might be right for
Treatment-resistant Depression
Janssen Research & Development, LLC 802
Large-scale testing (Phase 3)Study completedNCT01370499
What this trial is testing

LY2216684 in Participants With Major Depression Disorder

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 288
Next Page